Australia, July 5 -- Corcept Therapeutics Inc., owns the trademark (2501966) for 'ONLEVAYT' till Nov. 26, 2034.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders]
Type of Mark: Word
Date of Acceptance: Jan. 24
Registration Advertised: July 4
For further details contact ALLENS PATENT & T...